Chronic comorbidity in multiple sclerosis is associated with dissolved intimate relationships (P3.331)

Conclusions:These results indicate that comorbidity increases the relationship distress in persons with MS, further adding to the list of marginalization induced by the concomitant presence of other chronic disease with MS. Our results underscore the burden of comorbidity in MS on patients, their partners, families and society.Study Supported by: The Danish Multiple Sclerosis Society and Foundation for Research in Neurology.Disclosure: Dr. Thormann has received personal compensation for activities with Novartis and Teva as a scientific advisory board member or speaker. Dr. Sorensen has received personal compensation from Biogen Idec, Merck Serono, Novartis, Sanofi Genzyme, Teva CNS, GlaxoSmithKline, MedDay Pharmaceuticals, and Forward Pharma as an advisory board member. Dr. Solberg-Sorensen has received research support from Novarmi, Sanofi-Genzyme and Biogen. Dr. Koch-Henriksen has received personal compensation for activities with Novartis, Biogen Idec, and Bayer Schering as a speaker and advisory board member. Dr. Thygesen has nothing to disclose. Dr. Laursen has nothing to disclose. Dr. Magyari has received personal compensation for activities with Biogen, Sanofi Aventis, Genzyme, Merck Serono, Sanofi-Aventis, and Teva,
Source: Neurology - Category: Neurology Authors: Tags: Quality of Life, Symptoms and Symptomatic Therapy, Comorbidity, and Patient Reported Outcomes in Multiple Sclerosis Source Type: research